845 related articles for article (PubMed ID: 25374193)
1. Incidental abnormal FDG uptake in the prostate on 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography scans.
Kang PM; Seo WI; Lee SS; Bae SK; Kwak HS; Min K; Kim W; Kang DI
Asian Pac J Cancer Prev; 2014; 15(20):8699-703. PubMed ID: 25374193
[TBL] [Abstract][Full Text] [Related]
2. Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography images?
Hwang I; Chong A; Jung SI; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K; Ryu SB
Ann Nucl Med; 2013 Feb; 27(2):140-5. PubMed ID: 23076866
[TBL] [Abstract][Full Text] [Related]
3. Significance of incidental focal uptake in prostate on 18-fluoro-2-deoxyglucose positron emission tomography CT images.
Han EJ; H O J; Choi WH; Yoo IR; Chung SK
Br J Radiol; 2010 Nov; 83(995):915-20. PubMed ID: 20965901
[TBL] [Abstract][Full Text] [Related]
4. Does focal incidental 18F-FDG PET/CT uptake in the prostate have significance?
Brown AM; Lindenberg ML; Sankineni S; Shih JH; Johnson LM; Pruthy S; Kurdziel KA; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
Abdom Imaging; 2015 Oct; 40(8):3222-9. PubMed ID: 26239399
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.
Shiiba M; Ishihara K; Kimura G; Kuwako T; Yoshihara H; Sato H; Kondo Y; Tsuchiya S; Kumita S
Ann Nucl Med; 2012 Feb; 26(2):138-45. PubMed ID: 22069194
[TBL] [Abstract][Full Text] [Related]
6. Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation?
Reesink DJ; Fransen van de Putte EE; Vegt E; De Jong J; van Werkhoven E; Mertens LS; Bex A; van der Poel HG; van Rhijn BW; Horenblas S; Meijer RP
J Urol; 2016 Apr; 195(4 Pt 1):907-12. PubMed ID: 26598424
[TBL] [Abstract][Full Text] [Related]
7. Multicentre study of 18F-FDG-PET/CT prostate incidental uptake.
Bertagna F; Piccardo A; Dib B; Bertoli M; Fracassi F; Bosio G; Giubbini R; Biasiotto G; Giovanella L; Treglia G
Jpn J Radiol; 2015 Sep; 33(9):538-46. PubMed ID: 26153112
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk of cancer of incidental uptake in prostate identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Yang Z; Hu S; Cheng J; Xu J; Shi W; Zhu B; Zhang Y; Yao Z; Pan H; Zhang Y
Clin Imaging; 2014; 38(4):470-474. PubMed ID: 24629790
[TBL] [Abstract][Full Text] [Related]
9. The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level.
Minamimoto R; Uemura H; Sano F; Terao H; Nagashima Y; Yamanaka S; Shizukuishi K; Tateishi U; Kubota Y; Inoue T
Ann Nucl Med; 2011 Jan; 25(1):21-7. PubMed ID: 20931305
[TBL] [Abstract][Full Text] [Related]
10. Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study.
Peng J; He Y; Xu J; Sheng J; Cai S; Zhang Z
Colorectal Dis; 2011 Nov; 13(11):e374-8. PubMed ID: 21831098
[TBL] [Abstract][Full Text] [Related]
11. The usefulness of standardized uptake value in differentiation between benign and malignant thyroid lesions detected incidentally in 18F-FDG PET/CT examination.
Stangierski A; Woliński K; Czepczyński R; Czarnywojtek A; Lodyga M; Wyszomirska A; Janicka-Jedyńska M; Bączyk M; Ruchała M
PLoS One; 2014; 9(10):e109612. PubMed ID: 25296297
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer.
Jadvar H; Desai B; Ji L; Conti PS; Dorff TB; Groshen SG; Gross ME; Pinski JK; Quinn DI
Clin Nucl Med; 2012 Jul; 37(7):637-43. PubMed ID: 22691503
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of
Makis W; Ciarallo A
Mol Imaging Radionucl Ther; 2017 Jun; 26(2):76-82. PubMed ID: 28613200
[TBL] [Abstract][Full Text] [Related]
14. Incidental prostate ¹⁸F-FDG uptake without calcification indicates the possibility of prostate cancer.
Seino H; Ono S; Miura H; Morohashi S; Wu Y; Tsushima F; Takai Y; Kijima H
Oncol Rep; 2014 Apr; 31(4):1517-22. PubMed ID: 24503866
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of incidental FDG uptake in the prostate gland detected by PET/CT.
Sahin E; Elboga U; Kalender E; Basıbuyuk M; Demir HD; Celen YZ
Int J Clin Exp Med; 2015; 8(7):10577-85. PubMed ID: 26379847
[TBL] [Abstract][Full Text] [Related]
16. The value of 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer.
Igerc I; Kohlfürst S; Gallowitsch HJ; Matschnig S; Kresnik E; Gomez-Segovia I; Lind P
Eur J Nucl Med Mol Imaging; 2008 May; 35(5):976-83. PubMed ID: 18188560
[TBL] [Abstract][Full Text] [Related]
17. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical significance of incidental (18)F-fluoro-2-deoxyglucose uptake in prostate.
Kwon T; Jeong IG; You D; Hong JH; Ahn H; Kim CS
Korean J Urol; 2015 Apr; 56(4):288-94. PubMed ID: 25874042
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of FDG-PET/CT for Detection of Incidental Pre-Malignant and Malignant Colonic Lesions - Correlation with Colonoscopic and Histopathologic Findings.
Kunawudhi A; Wong AK; Alkasab TK; Mahmood U
Asian Pac J Cancer Prev; 2016; 17(8):4143-7. PubMed ID: 27644675
[TBL] [Abstract][Full Text] [Related]
20. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
